Brain glutathione and GABA+ levels in autistic children

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication challenges and repetitive behaviors. Altered neurometabolite levels, including glutathione (GSH) and gamma-aminobutyric acid (GABA), have been proposed as potential contributors to the biology underlying ASD. This study investigated whether cerebral GSH or GABA levels differ between a cohort of children aged 8-12 years with ASD (n = 52) and typically developing children (TDC, n = 49). A comprehensive analysis of GSH and GABA levels in multiple brain regions, including the primary motor cortex (SM1), thalamus (Thal), medial prefrontal cortex (mPFC), and supplementary motor area (SMA), was conducted using single-voxel HERMES MR spectroscopy at 3T. The results revealed no significant differences in cerebral GSH or GABA levels between the ASD and TDC groups across all examined regions. These findings suggest that the concentrations of GSH (an important antioxidant and neuromodulator) and GABA (a major inhibitory neurotransmitter) do not exhibit marked alterations in children with ASD compared to TDC. A statistically significant positive correlation was observed between GABA levels in the SM1 and Thal regions with ADHD inattention scores. No significant correlation was found between metabolite levels and hyper/impulsive scores of ADHD, measures of core ASD symptoms (ADOS-2, SRS-P) or adaptive behavior (ABAS-2). While both GSH and GABA have been implicated in various neurological disorders, the current study provides valuable insights into the specific context of ASD and highlights the need for further research to explore other neurochemical alterations that may contribute to the pathophysiology of this complex disorder.

Assessment of the Impact of Turbo Factor on Image Quality and Tissue Volumetrics in Brain Magnetic Resonance Imaging Using the Three-Dimensional T1-Weighted (3D T1W) Sequence

Background

The 3D T1W turbo field echo sequence is a standard imaging method for acquiring high-contrast images of the brain. However, the contrast-to-noise ratio (CNR) can be affected by the turbo factor, which could affect the delineation and segmentation of various structures in the brain and may consequently lead to misdiagnosis. This study is aimed at evaluating the effect of the turbo factor on image quality and volumetric measurement reproducibility in brain magnetic resonance imaging (MRI).

Methods

Brain images of five healthy volunteers with no history of neurological diseases were acquired on a 1.5 T MRI scanner with varying turbo factors of 50, 100, 150, 200, and 225. The images were processed and analyzed with FreeSurfer. The influence of the TFE factor on image quality and reproducibility of brain volume measurements was investigated. Image quality metrics assessed included the signal-to-noise ratio (SNR) of white matter (WM), CNR between gray matter/white matter (GM/WM) and gray matter/cerebrospinal fluid (GM/CSF), and Euler number (EN). Moreover, structural brain volume measurements of WM, GM, and CSF were conducted.

Results

Turbo factor 200 produced the best SNR (median = 17.01) and GM/WM CNR (median = 2.29), but turbo factor 100 offered the most reproducible SNR (IQR = 2.72) and GM/WM CNR (IQR = 0.14). Turbo factor 50 had the worst and the least reproducible SNR, whereas turbo factor 225 had the worst and the least reproducible GM/WM CNR. Turbo factor 200 again had the best GM/CSF CNR but offered the least reproducible GM/CSF CNR. Turbo factor 225 had the best performance on EN (-21), while turbo factor 200 was next to the most reproducible turbo factor on EN (11). The results showed that turbo factor 200 had the least data acquisition time, in addition to superior performance on SNR, GM/WM CNR, GM/CSF CNR, and good reproducibility characteristics on EN. Both image quality metrics and volumetric measurements did not vary significantly (p > 0.05) with the range of turbo factors used in the study by one-way ANOVA analysis.

Conclusion

Since no significant differences were observed in the performance of the turbo factors in terms of image quality and volume of brain structure, turbo factor 200 with a 74% acquisition time reduction was found to be optimal for brain MR imaging at 1.5 T.

A SWOT analysis of artificial intelligence in diagnostic imaging in the developing world: making a case for a paradigm shift

Diagnostic imaging (DI) refers to techniques and methods of creating images of the body’s internal parts and organs with or without the use of ionizing radiation, for purposes of diagnosing, monitoring and characterizing diseases. By default, DI equipment are technology based and in recent times, there has been widespread automation of DI operations in high-income countries while low and middle-income countries (LMICs) are yet to gain traction in automated DI. Advanced DI techniques employ artificial intelligence (AI) protocols to enable imaging equipment perceive data more accurately than humans do, and yet automatically or under expert evaluation, make clinical decisions such as diagnosis and characterization of diseases. In this narrative review, SWOT analysis is used to examine the strengths, weaknesses, opportunities and threats associated with the deployment of AI-based DI protocols in LMICs. Drawing from this analysis, a case is then made to justify the need for widespread AI applications in DI in resource-poor settings. Among other strengths discussed, AI-based DI systems could enhance accuracies in diagnosis, monitoring, characterization of diseases and offer efficient image acquisition, processing, segmentation and analysis procedures, but may have weaknesses regarding the need for big data, huge initial and maintenance costs, and inadequate technical expertise of professionals. They present opportunities for synthetic modality transfer, increased access to imaging services, and protocol optimization; and threats of input training data biases, lack of regulatory frameworks and perceived fear of job losses among DI professionals. The analysis showed that successful integration of AI in DI procedures could position LMICs towards achievement of universal health coverage by 2030/2035. LMICs will however have to learn from the experiences of advanced settings, train critical staff in relevant areas of AI and proceed to develop in-house AI systems with all relevant stakeholders onboard.

Dynamic MR Spectroscopy of brain metabolism using a non-conventional spectral averaging scheme

PURPOSE

MRS acquisition based on the blood oxygenation level dependent (BOLD) contrast mechanism was implemented at 3T to investigate the impact of a non-conventional spectral averaging scheme (determined by the number of RF excitations, NEX) on the dynamics of cerebral metabolism during neuroactivation. Using NEX=2, water and metabolite BOLD responses were compared to previous results from standard experiments.

METHODS

Spectra were recorded from the visual cortex of five healthy volunteers during single and block visual stimulations. The height, width and area of the spectral peaks were calculated (using SAGE v7) in order to estimate their percentage changes from baseline (representing the BOLD change) following visual stimulation. BOLD changes were statistically significant at a significance level of p<0.05 by paired t-test.

RESULTS

Significantly greater BOLD changes in all spectra were observed in the single than block stimulation (p<0.05). The water resonance showed significant (p<0.01) BOLD changes in all peak parameters in both paradigms. All metabolites showed significant increase in spectral height (p<0.01) in the single paradigm, but none of them (except the height of Cho) showed significant BOLD response in the block paradigm. BOLD changes observed in the block paradigm were generally lower than reported changes.

CONCLUSIONS

The time interval of 6s offered by NEX=2 during which each line of spectral data is recorded by the scanner is rather long, leading to some BOLD data loss particularly in a block experimental design.